Vista Equipo: Use of intracranial translucency measurement in first trimester, beyond spina bifida

Use of intracranial translucency measurement in first trimester, beyond spina bifida

Background: The intracranial translucency (IT) is described as echolucid space located in the fetal central nervous system corresponding to the fourth ventricle. Alteration in the first trimester is associated with neural tube defects (NTDs). Objective: Describe the technique and normal values of tr...

Descripción completa

Detalles Bibliográficos
Autores Principales:	Buitrago-Leal M., Molina-Giraldo S.
Formato:	Artículo (Article)
Lenguaje:	Inglés (English)
Publicado:	2014
Materias:	Female Humans Neural Tube Defects Nuchal Translucency Measurement Observer Variation Pregnancy Pregnancy Trimester, First Spinal Dysraphism First trimester screening Intracranial translucency Prenatal diagnosis Spine bifida Prenatal Ultrasonography
Acceso en línea:	https://repository.urosario.edu.co/handle/10336/24155

id	ir-10336-24155
recordtype	dspace
spelling	ir-10336-241552022-05-02T12:37:21Z Use of intracranial translucency measurement in first trimester, beyond spina bifida Utilidad de la medición de la translucencia intracraneal en el primer trimestre: Más allá de la espina bífida Buitrago-Leal M. Molina-Giraldo S. Female Humans Neural Tube Defects Nuchal Translucency Measurement Observer Variation Pregnancy Pregnancy Trimester, First Spinal Dysraphism First trimester screening Intracranial translucency Prenatal diagnosis Spine bifida Prenatal Ultrasonography Background: The intracranial translucency (IT) is described as echolucid space located in the fetal central nervous system corresponding to the fourth ventricle. Alteration in the first trimester is associated with neural tube defects (NTDs). Objective: Describe the technique and normal values of translucency and everything that makes this resourse a useful option in the detection of defects and abnormalities. Methods: We conducted an electronic search of the literature registered in: PubMed, Ovid, and ProQuest, between September 2009 and January 2013. Results: It describes technical and normal values, factors affecting measurement, intra and inter-observer variability, regarding the screening and diagnosis of NTDs. Conclusion: The IT should be included in the checklist of valuable structures on 11 to 13 ultrasound; its alteration should be related not just o NTDs but posterior fossa anomalies. 2014 2020-05-26T00:09:21Z info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion 3009041 https://repository.urosario.edu.co/handle/10336/24155 eng info:eu-repo/semantics/openAccess application/pdf instname:Universidad del Rosario
institution	EdocUR - Universidad del Rosario
collection	DSpace
language	Inglés (English)
topic	Female Humans Neural Tube Defects Nuchal Translucency Measurement Observer Variation Pregnancy Pregnancy Trimester, First Spinal Dysraphism First trimester screening Intracranial translucency Prenatal diagnosis Spine bifida Prenatal Ultrasonography
spellingShingle	Female Humans Neural Tube Defects Nuchal Translucency Measurement Observer Variation Pregnancy Pregnancy Trimester, First Spinal Dysraphism First trimester screening Intracranial translucency Prenatal diagnosis Spine bifida Prenatal Ultrasonography Buitrago-Leal M. Molina-Giraldo S. Use of intracranial translucency measurement in first trimester, beyond spina bifida
description	Background: The intracranial translucency (IT) is described as echolucid space located in the fetal central nervous system corresponding to the fourth ventricle. Alteration in the first trimester is associated with neural tube defects (NTDs). Objective: Describe the technique and normal values of translucency and everything that makes this resourse a useful option in the detection of defects and abnormalities. Methods: We conducted an electronic search of the literature registered in: PubMed, Ovid, and ProQuest, between September 2009 and January 2013. Results: It describes technical and normal values, factors affecting measurement, intra and inter-observer variability, regarding the screening and diagnosis of NTDs. Conclusion: The IT should be included in the checklist of valuable structures on 11 to 13 ultrasound; its alteration should be related not just o NTDs but posterior fossa anomalies.
format	Artículo (Article)
author	Buitrago-Leal M. Molina-Giraldo S.
author_facet	Buitrago-Leal M. Molina-Giraldo S.
author_sort	Buitrago-Leal M.
title	Use of intracranial translucency measurement in first trimester, beyond spina bifida
title_short	Use of intracranial translucency measurement in first trimester, beyond spina bifida
title_full	Use of intracranial translucency measurement in first trimester, beyond spina bifida
title_fullStr	Use of intracranial translucency measurement in first trimester, beyond spina bifida
title_full_unstemmed	Use of intracranial translucency measurement in first trimester, beyond spina bifida
title_sort	use of intracranial translucency measurement in first trimester, beyond spina bifida
publishDate	2014
url	https://repository.urosario.edu.co/handle/10336/24155
_version_	1740172320418299904
score	12,131701

Use of intracranial translucency measurement in first trimester, beyond spina bifida

Ejemplares similares